Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1128)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
848
Price
$583.41
Total Value
$494.74K
Shares Held After
41,225
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,070
Price
$582.46
Total Value
$623.23K
Shares Held After
42,073
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
238
Price
$585.36
Total Value
$139.32K
Shares Held After
18,876
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
410
Price
$581.71
Total Value
$238.50K
Shares Held After
43,143
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
482
Price
$584.49
Total Value
$281.73K
Shares Held After
19,114
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,009
Price
$583.55
Total Value
$588.80K
Shares Held After
19,596
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
277
Price
$579.92
Total Value
$160.64K
Shares Held After
43,553
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
461
Price
$579.09
Total Value
$266.96K
Shares Held After
43,830
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
983
Price
$582.47
Total Value
$572.57K
Shares Held After
20,605
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
488
Price
$581.66
Total Value
$283.85K
Shares Held After
21,588
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
165
Price
$577.94
Total Value
$95.36K
Shares Held After
44,291
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
340
Price
$579.86
Total Value
$197.15K
Shares Held After
22,076
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,148
Price
$576.87
Total Value
$662.25K
Shares Held After
44,456
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
500
Price
$578.90
Total Value
$289.45K
Shares Held After
22,416
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,179
Price
$575.96
Total Value
$679.05K
Shares Held After
45,604
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
687
Price
$577.27
Total Value
$396.58K
Shares Held After
22,916
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
570
Price
$575.07
Total Value
$327.79K
Shares Held After
46,783
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,398
Price
$576.37
Total Value
$805.77K
Shares Held After
23,603
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,683
Price
$573.57
Total Value
$965.31K
Shares Held After
47,353
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,010
Price
$575.41
Total Value
$581.16K
Shares Held After
25,001
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
977
Price
$572.41
Total Value
$559.24K
Shares Held After
49,036
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
442
Price
$574.09
Total Value
$253.75K
Shares Held After
26,011
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,543
Price
$573.45
Total Value
$884.83K
Shares Held After
26,453
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
880
Price
$572.33
Total Value
$503.65K
Shares Held After
27,996
% of Holdings
3.0%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
40,690
Price
$3.88
Total Value
$157.97K
Shares Held After
12,114,700
% of Holdings
0.3%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
15,000
Price
$23.61
Total Value
$354.15K
Shares Held After
362,152
% of Holdings
4.0%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
2,948
Price
$44.52
Total Value
$131.24K
Shares Held After
2,964,774
% of Holdings
0.1%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
2,948
Price
$44.52
Total Value
$131.24K
Shares Held After
2,964,774
% of Holdings
0.1%
Zivo Bioscience, Inc. (ZIVO)
STROME MARK E — 10% Owner
Shares
100,000
Price
$2.00
Total Value
$200.00K
Shares Held After
572,942
% of Holdings
17.5%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
52,397
Price
$44.68
Total Value
$2.34M
Shares Held After
2,967,722
% of Holdings
1.7%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
52,397
Price
$44.68
Total Value
$2.34M
Shares Held After
2,967,722
% of Holdings
1.7%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,441
Price
$48.06
Total Value
$117.30K
Shares Held After
25,000
% of Holdings
8.9%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,419
Price
$47.39
Total Value
$114.64K
Shares Held After
27,441
% of Holdings
8.1%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
140
Price
$45.81
Total Value
$6.41K
Shares Held After
29,860
% of Holdings
0.5%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
426,005
Price
$40.32
Total Value
$17.18M
Shares Held After
6,709,228
% of Holdings
6.0%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
458,411
Price
$16.28
Total Value
$7.46M
Shares Held After
2,739,208
% of Holdings
14.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
416
Price
$31.33
Total Value
$13.03K
Shares Held After
69,792
% of Holdings
0.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.57
Total Value
$277.70K
Shares Held After
403,822
% of Holdings
4.5%
Nuvation Bio Inc. (NUVB)
Wentworth Kerry — CHIEF REGULATORY OFFICER
Shares
36,750
Price
$5.01
Total Value
$184.28K
Shares Held After
53,000
% of Holdings
40.9%
Nuvation Bio Inc. (NUVB)
Liu Dongfang — CHIEF MEDICAL OFFICER
Shares
50,000
Price
$5.02
Total Value
$251.00K
Shares Held After
18,000
% of Holdings
73.5%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
20,225
Price
$39.99
Total Value
$808.84K
Shares Held After
246,426
% of Holdings
7.6%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
18,667
Price
$96.50
Total Value
$1.80M
Shares Held After
262,692
% of Holdings
6.6%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
211,974
Price
$20.29
Total Value
$4.30M
Shares Held After
4,332,799
% of Holdings
4.7%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
18,839
Price
$40.60
Total Value
$764.96K
Shares Held After
1,423,095
% of Holdings
1.3%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
34,636
Price
$0.73
Total Value
$25.28K
Shares Held After
177,821
% of Holdings
19.5%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
9,550
Price
$20.22
Total Value
$193.07K
Shares Held After
462,577
% of Holdings
2.0%
KalVista Pharmaceuticals, Inc. (KALV)
Piekos Brian — Chief Financial Officer
Shares
1,862
Price
$20.22
Total Value
$37.64K
Shares Held After
18,150
% of Holdings
9.3%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
1,862
Price
$20.22
Total Value
$37.64K
Shares Held After
51,391
% of Holdings
3.5%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,686
Price
$20.22
Total Value
$54.30K
Shares Held After
142,547
% of Holdings
1.8%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
40,114
Price
$3.57
Total Value
$143.25K
Shares Held After
12,074,010
% of Holdings
0.3%
Showing 351–400 of 1128 transactions (page 8 of 23)